Indian Nivolumab Exporters: Complete Supplier Ranking with Market Share — 23 Manufacturers (2026) — TransData Nexus

Q: Who is the largest nivolumab supplier from India?

DR.REDDY'S LABORATORIES LTD is the largest nivolumab exporter from India with a 25.3% market share and export value of $577.4K.

Q: How many nivolumab suppliers are there in India?

There are 23 active nivolumab exporters in India, collectively shipping $2.3M worth of nivolumab across 144 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top nivolumab suppliers from India?

The top 5 nivolumab suppliers from India — DR.REDDY'S LABORATORIES LTD, CORSANTRUM TECHNOLOGY, VAMA LIFECARE PRIVATE LIMITED, MODERN DRUG HOUSE, SPECIALITY MEDICINES LIMITED — together control 36.0% of total nivolumab export value from India.

Suresh Sormare

Nivolumab

India Pharmaceutical Trade Intelligence

$2.3M23 Suppliers13 CountriesHS 30049099

ExportsIndia → SINGAPORE46.0%India → RUSSIA33.9%

ImportsUNITED STATES → India$48.1B SWITZERLAND → India$15.1M

Nivolumab Suppliers from India (2026) — 23 Exporters, $2.3M Market | TransData Nexus | TransData Nexus

Who Exports Nivolumab from India — 23 Suppliers Behind a $2.3M Market

India's nivolumab export market is supplied by 23 active exporters who collectively shipped $2.3M across 144 shipments. DR.REDDY'S LABORATORIES LTD leads with a 25.3% market share, followed by CORSANTRUM TECHNOLOGY and VAMA LIFECARE PRIVATE LIMITED. The top 5 suppliers together control 36.0% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Nivolumab Suppliers & Exporters — 23 manufacturers, $2.3M export market, top destinations and formulations — Nivolumab supplier data — 23 exporters · $2.3M market · 144 shipmentsTransData Nexus · Indian Customs Data

Top Nivolumab Exporters from India — Ranked by Export Value

DR.REDDY'S LABORATORIES LTD is the leading nivolumab exporter from India, holding a 25.3% share of the $2.3M market across 144 shipments from 23 exporters. The top 5 suppliers — DR.REDDY'S LABORATORIES LTD, CORSANTRUM TECHNOLOGY, VAMA LIFECARE PRIVATE LIMITED, MODERN DRUG HOUSE, SPECIALITY MEDICINES LIMITED — collectively control 36.0% of total export value, indicating a competitive market. Individual shares are: DR.REDDY'S LABORATORIES LTD (25.3%), CORSANTRUM TECHNOLOGY (5.0%), VAMA LIFECARE PRIVATE LIMITED (3.2%), MODERN DRUG HOUSE (1.3%), SPECIALITY MEDICINES LIMITED (1.3%).

Top Nivolumab Exporters from India

Ranked by export value · 23 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Nivolumab Exporters from India — Ranked by Export Value. 23 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Nivolumab exporters

Certification and compliance status for top Nivolumab suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Dr. Reddy's Laboratories Ltd	Approved	Yes	Yes	Not verified	FDA issued a warning letter on November 5, 2015, for cGMP violations; the letter

TransData Nexus reviewed the regulatory standing of 1 leading Nivolumab exporters from India. 1 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Nivolumab sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city hosts numerous API manufacturers, including Neuland Laboratories, which specializes in the development and production of APIs and advanced intermediates. The presence of such companies underscores Hyderabad's critical role in supplying essential components for biologics like Nivolumab.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Ahmedabad-based Zydus Lifesciences has recently launched Tishtha™, the world's first biosimilar of Nivolumab, marking a significant advancement in oncology treatments. This development highlights the region's capability in producing complex biologics and biosimilars, contributing to both domestic healthcare and export markets.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for Indian pharmaceuticals. Mumbai, being the financial capital, houses numerous pharmaceutical companies with extensive export operations. The region's well-established infrastructure and proximity to major ports facilitate the efficient export of pharmaceuticals, including Nivolumab, to international markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Nivolumab exporters from India

February 24, 2022

M&A

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires Nimbus Health GmbH

Dr. Reddy's Laboratories Ltd. acquired Nimbus Health GmbH, a German pharmaceutical company, expanding its footprint in the European market. - IMPACT: This acquisition is expected to enhance Dr. Reddy's distribution network in Europe, potentially increasing Nivolumab exports to the region.

Impact: This acquisition is expected to enhance Dr. Reddy's distribution network in Europe, potentially increasing Nivolumab exports to the region.

April 8, 2022

M&A

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's merges with Dr. Reddy's Holdings Limited

Dr. Reddy's Laboratories Ltd. completed the merger with its subsidiary, Dr. Reddy's Holdings Limited, consolidating its operations and streamlining corporate structure. - IMPACT: The merger is anticipated to improve operational efficiency, potentially leading to increased production and export capacity for Nivolumab.

Impact: The merger is anticipated to improve operational efficiency, potentially leading to increased production and export capacity for Nivolumab.

Common Questions — Nivolumab Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which nivolumab supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, DR.REDDY'S LABORATORIES LTD leads with 15 recorded shipments worth $577.4K. CORSANTRUM TECHNOLOGY (22 shipments) and VAMA LIFECARE PRIVATE LIMITED (7 shipments) are also established high-volume exporters.

Q How many nivolumab manufacturers are there in India?

India has 23 active nivolumab exporters with a combined export market of $2.3M across 144 shipments to 13 countries. The top 5 suppliers hold 36.0% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for nivolumab from India?

Average FOB unit price: $583.34 per unit, ranging from $0.71 to $1824.74. Average shipment value: $15.9K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Nivolumab

Nivolumab

Who Exports Nivolumab from India — 23 Suppliers Behind a $2.3M Market

Top Nivolumab Exporters from India — Ranked by Export Value

Top Nivolumab Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's acquires Nimbus Health GmbH

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's merges with Dr. Reddy's Holdings Limited

Common Questions — Nivolumab Suppliers from India

Q Which nivolumab supplier from India is the most reliable for bulk orders?

Q How many nivolumab manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for nivolumab from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Dr. Reddy's Laboratories Ltd. — Dr. Reddy's merges with Dr. Reddy's Laboratories LLC, Russia

Analysis Methodology